MSN Laboratories Private Limited — Sunitinib Exporter Profile
Indian Pharmaceutical Exporter · #4 for Sunitinib · $1.0M export value · DGFT Verified
MSN Laboratories Private Limited is the #4 Indian exporter of Sunitinib with $1.0M in export value and 42 verified shipments. MSN Laboratories Private Limited holds a 1.6% market share in Sunitinib exports across 5 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Sunitinib Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Sunitinib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PERU | $212.1K | 5 | 38.9% |
| UNITED STATES | $117.4K | 4 | 21.5% |
| UNITED ARAB EMIRATES | $100.0K | 2 | 18.3% |
| MALTA | $65.7K | 21 | 12.0% |
| UNITED KINGDOM | $49.9K | 10 | 9.2% |
MSN Laboratories Private Limited exports Sunitinib to 5 countries. The largest destination is PERU accounting for 38.9% of MSN Laboratories Private Limited's Sunitinib shipments, followed by UNITED STATES (21.5%) and UNITED ARAB EMIRATES (18.3%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sunitinib from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | MALTA | $195.0K | 10 |
| MSN LABS PERU SAC | PERU | $162.1K | 4 |
| WORLD HEALTH ORGANIZATION WAREHOUSE | UNITED ARAB EMIRATES | $100.0K | 2 |
| MSN LABORATORIES EUROPE LIMITED | UNITED KINGDOM | $18.8K | 4 |
| MSN LABORATORIES EUROPE LIMITED C | UNITED KINGDOM | $16.4K | 2 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $14.7K | 6 |
| MSN LABORATORIES EUROPE LIMITED . | UNITED KINGDOM | $14.6K | 3 |
| PHARMADOX HEALTHCARE LTD., | MALTA | $11.8K | 6 |
| PHARMADOX HEALTHCARE LTD | MALTA | $11.5K | 4 |
| ARC PHARMA (UK) LIMITED | UNITED KINGDOM | $100 | 1 |
MSN Laboratories Private Limited supplies Sunitinib to 10 buyers globally. The largest buyer is TO THE ORDER OF (MALTA), followed by MSN LABS PERU SAC (PERU) and WORLD HEALTH ORGANIZATION WAREHOUSE (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sunitinib Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $9.9M worth of Sunitinib through 607 shipments from 114 suppliers to 76 countries, serving 188 buyers globally. MSN Laboratories Private Limited contributes $1.0M to this total, accounting for 1.6% of India's Sunitinib exports. MSN Laboratories Private Limited ships Sunitinib to 5 countries through 10 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Sunitinib Exports?
MSN Laboratories Private Limited's average Sunitinib shipment value is $23.9K per consignment, based on 42 shipments totaling $1.0M. The largest destination is PERU (38.9% of MSN Laboratories Private Limited's Sunitinib exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Sunitinib Exporters?
MSN Laboratories Private Limited ranks #4 among 114 Indian Sunitinib exporters with a 1.6% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.9M), MSN LABORATORIES PRIVATE LIMITED ($1.0M), SUN PHARMACEUTICAL INDUSTRIES LTD ($450.0K). MSN Laboratories Private Limited processed 42 shipments to 5 destination countries.
What Sunitinib Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SUNITINIB 50 MG 1X28S AURUGULF AE | $50.0K | 1 |
| SUNITINIB 12 5MG 1X28S AURUGULF AE | $50.0K | 1 |
| SUTYKA 25MG (SUNITINIB 2X14 S) MSN -PE | $50.0K | 1 |
| SUTYKA 25MGSUNITINIB 2x14's MSN -PE | $50.0K | 1 |
| Sutkya 25 mg (Sunitinib 2x14's) MSN-PE BATCH NO:CRE11042A | $50.0K | 1 |
| SUTYAKA 25 MG (SUNITINIB 2X14"S)MSN ( QTY: 2033 PAC AS PER INVOICE ) | $50.0K | 1 |
| SUNITINIB MALATE CAPSULES 37.50MG 28'S | $50.0K | 1 |
| SUNITINIB MALATE CAPSULES 25MG 28'S | $43.8K | 1 |
| SUNITINIB MALATE CAPSULES 50MG 28'S | $17.2K | 1 |
| SUNITINIB HARD CAPSULE 12.5MG 28S | $16.4K | 2 |
MSN Laboratories Private Limited exports 39 distinct Sunitinib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SUNITINIB 50 MG 1X28S AURUGULF AE with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Sunitinib to Key Markets
What MSN Laboratories Private Limited must comply with to export Sunitinib to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Sunitinib Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $6.9M | 138 | 7 | $50.0K |
| 4 | MSN LABORATORIES PRIVATE LIMITED ★ | $1.0M | 42 | 5 | $23.9K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD | $450.0K | 9 | 1 | $50.0K |
| 6 | JODAS EXPOIM PRIVATE LIMITED | $428.2K | 16 | 2 | $26.8K |
MSN Laboratories Private Limited ranks #4 among 114 Indian Sunitinib exporters. Average shipment value of $23.9K compared to the market average of $87.1K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD.
Which Indian Ports Ship Sunitinib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 177 | 29.2% |
| SAHAR AIR | 118 | 19.4% |
| DELHI AIR | 40 | 6.6% |
| DELHI AIR CARGO ACC (INDEL4) | 38 | 6.3% |
| Bombay Air Cargo | 25 | 4.1% |
| HYDERABAD ACC (INHYD4) | 22 | 3.6% |
| HYDERABAD AIR | 16 | 2.6% |
| NHAVA SHEVA SEA (INNSA1) | 15 | 2.5% |
What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Sunitinib Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Sunitinib, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sunitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sunitinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 42 individual customs records matching MSN Laboratories Private Limited exporting Sunitinib, covering 39 formulations to 5 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 188+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sunitinib Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Sunitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Sunitinib Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sunitinib. For current shipment-level data, contact TransData Nexus.